Wong, G., Zhou, J., Liu, J., Wu, Z., Xu, X., Li, T., Xu, D., Schumacher, S., Puschhof, J., McFarland, J., Zou, C., Dulak, A., Henderson, L., Xu, P., O'Day, E., Rendak, R., Liao, W., Cecchi, F., Hembrough, T., Schwartz, S., Szeto, C., Rustgi, A., Wong, K., Diehl, J., Jensen, K., Graziano, F., Ruzzo, A., Fereshetian, S., Mertins, P., Carr, S., Beroukhim, R., Nakamura, K., Oki, E., Watanabe, M., Baba, H., Imamura, Y., Catenacci, D., & Bass, A. (2018). author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nature medicine, 24, 1627. http://access.bl.uk/ark:/81055/vdc_100084758608.0x000120